Expression and Its Clinical Significance of AMP-activated Protein Kinase in Esophageal Squamous Cell Carcinoma

ZHAO Song-yuan, ZHANG Xue-mei, MA Hong-sheng

Abstract

To investigate the expression and its possible function of AMP-activated protein kinase(AMPK) in the occurrence of esophageal squamous cell carcinoma(ESCC). Methods The tissue samples were collected from 40 fresh ESCC and 40 normal esophagus, and the expression of AMPK downstream substrates p-ACC and ACC were tested by Western-blot, then the correlations of p-ACC and ACC expression to the clinicopathologic characterisics were analyzed. Results The expression of p-ACC in ESCC was lower than that in normal tissues, with significant statistical difference (P<0.05). The down-regulation ratio of p-ACC in poorly-differentiated ESCC was 81.8%(9/11), which was significantly higher than that in moderately and well-differentiated ESCC(3.5%, 1/29). There was no correlation of p-ACC down-regulation with age, gender, TNM stage and lymph node metastasis(P>0.05). Conclusion The expression of p-ACC was down-regulation in ESCC, and the down-regulation is associated with tumor cell differentiation.

 

Keywords: AMP-activated protein kinase(AMPK), Esophageal squamous cell carcinoma, Energy metabolic

 

Full Text:

PDF


References


Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell.2001; 144(5): 646-674.

Mitchelhill KI. Stapleton D. Gao G. et al. Mammalian AМР- activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snfl protein kinase. J Biol Chem, 1994;269(4) ;2361-2364.

Viollet B, Horman S. Leclerc J. et al. AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol, 2010; 45 ( 4); 276-295.

Carling D'Zammit VA,Hardie DG. A common bicyclic protein kinase cascade inactivates the regulatoryenzymes of fatty acid and cholesterol biosynthesis. FEBS Lett, 1987; 223 ( 2 ); 217- 222.

Mitchelhill KI, Stapleton D, Gao G, et al. Mammalian AMP- activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snfl protein kinase. J Biol Chem, 1994;269(4) ;2361-2364.

Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol, 2007; 8 (10):774-785.

Wang W,Guan KL. AMP-activated protein kinase and cancer. Acta Physiol (Oxf) ,2009; 196( 1): 55-63,

Woodard J, Joshi S, Viollet B, et al. AMPK as a therapeutic target in renal cell carcinoma. Cancer Biol Ther,2010; 10(11); 1168-1177.

Woodard J, Sassano A, Hay N, et al. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma. Clin Cancer Res, 2008; 14 ( 14 ); 4640- 4649.

Hadad SM, Baker L. Quinlan PR, et al. Histological evaluation of AMPK signalling in primary breast cancer. BMC Cancer,2009;9;307. doi:10. 1186/1471-2407-9-307. ZakikhaniM, Dowling R, Fantus IG, et al. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res,2006;66(21); 10269-10273.

Kato K, Ogura T, Kishimoto A, et al. Critical roles of AMP- activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene, 2002; 21(39):6082-6090.


Refbacks

  • There are currently no refbacks.